Essex Bio-Technology's total assets for Q4 2024 were HK$2.98B, an increase of 0.58% from the previous quarter. HK:1061 total liabilities were HK$859.33M for the fiscal quarter, a -9.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.